Pfizer migraine nasal spray snags FDA approval for summer launch
People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray intended to treat migraines in adults. Pfizer produces the…
#fda #pfizer #zavzpret #newsoffdas #zavzpretmarks #angelahwang #pifizer #newyorkcity #kathleenmullin #stamford